Comparative analysis across TCGA pan-cancer gene-expression data confirmed GPR139 was highly expressed in subsets of PCPG, while also in CNS malignancies and a subset of breast adenocarcinomas (Fig. 7b). This evidence concerns the gene GPR139 and breast adenocarcinoma.